Pancreatic Cancer and Cachexia—Metabolic Mechanisms and Novel Insights
Abstract Cachexia is a major characteristic of multiple non-malignant diseases, advanced and metastatic cancers and it is highly prevalent in…
Abstract Cachexia is a major characteristic of multiple non-malignant diseases, advanced and metastatic cancers and it is highly prevalent in…
Abstract Cachexia is a common term for the wasting symptoms which may appear in almost every chronic illness, such as…
Abstract The true incidence of anorexia secondary to human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) and cancer is not well…
Abstract In 1993, megestrol acetate (MA) was approved by the US Food and Drug Administration for the treatment of anorexia,…
Abstract Muscle wasting in cancer is a common and often occult condition that can occur prior to overt signs of…
Abstract Since the beginning of the HIV/AIDS epidemic, weight loss has been a common complaint for patients. The use of…
Abstract Over the last decade, we have gained new insight into the pathophysiology of cachexia associated with pancreatic cancer. Unfortunately,…
Abstract About half of all cancer patients show a syndrome of cachexia, characterized by anorexia and loss of adipose tissue…